IL33 and allergic disease: Mechanistically, it was shown that the release of IL-33 was essential for the induction of allergic reactions, since, for example, a blockade of either IL-33 production or IL-33 receptor ST2 were sufficient to both suppress the observed Ova-induced allergic reactions and to reduce mouse mast cell protease 1 (mMCP1) secretion [68].